Literature DB >> 18799589

Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA.

Erkko Ylösmäki1, Tanja Hakkarainen, Akseli Hemminki, Tapio Visakorpi, Raul Andino, Kalle Saksela.   

Abstract

MicroRNAs have emerged as important players in tissue-specific mammalian gene regulation and have also been exploited in experimental targeting of gene expression. We have constructed a recombinant adenovirus that contains sequences complementary to the liver-specific microRNA 122 (miR122) in the 3' untranslated region of the E1A gene. In Huh7 cells, which resemble normal hepatocytes in expressing high levels of miR122, this feature resulted in strongly reduced levels of E1A mRNA and protein. This property allowed us to generate a novel recombinant adenovirus that was severely attenuated in cells of hepatic origin but replicated normally in other cells. This strategy may be useful in circumventing liver toxicity associated with the systemic delivery of oncolytic adenoviruses. These data provide the first example of exploiting differential microRNA expression patterns to alter the natural tropism of a DNA virus. In addition, these results suggest that other microRNAs expressed in a tissue- or transformation-specific manner may also be used for the targeting of adenoviral replication and that the same principle may be applied to other viruses that have shown promise as oncolytic or gene delivery platforms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799589      PMCID: PMC2573287          DOI: 10.1128/JVI.01608-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches.

Authors:  Leonid Gitlin; Jeffrey K Stone; Raul Andino
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 3.  Oncolytic viral therapies - the clinical experience.

Authors:  Manish Aghi; Robert L Martuza
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

Review 4.  Oncolytic adenoviruses - selective retargeting to tumor cells.

Authors:  J Michael Mathis; Mariam A Stoff-Khalili; David T Curiel
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

5.  A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication.

Authors:  Robert E Edge; Theresa J Falls; Christopher W Brown; Brian D Lichty; Harold Atkins; John C Bell
Journal:  Mol Ther       Date:  2008-06-17       Impact factor: 11.454

6.  Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.

Authors:  Steven E Raper; Narendra Chirmule; Frank S Lee; Nelson A Wivel; Adam Bagg; Guang-ping Gao; James M Wilson; Mark L Batshaw
Journal:  Mol Genet Metab       Date:  2003 Sep-Oct       Impact factor: 4.797

7.  Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates.

Authors:  Nicola Brunetti-Pierri; Donna J Palmer; Arthur L Beaudet; K Dee Carey; Milton Finegold; Philip Ng
Journal:  Hum Gene Ther       Date:  2004-01       Impact factor: 5.695

8.  A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization.

Authors:  Atique Ahmed; Jill Thompson; Lisa Emiliusen; Stephen Murphy; R Daniel Beauchamp; Kaori Suzuki; Ramon Alemany; Kevin Harrington; Richard G Vile
Journal:  Nat Biotechnol       Date:  2003-06-08       Impact factor: 54.908

9.  miRNAMap: genomic maps of microRNA genes and their target genes in mammalian genomes.

Authors:  Paul W C Hsu; Hsien-Da Huang; Sheng-Da Hsu; Li-Zen Lin; Ann-Ping Tsou; Ching-Ping Tseng; Peter F Stadler; Stefan Washietl; Ivo L Hofacker
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

10.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

View more
  59 in total

1.  In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAs.

Authors:  Kurt I Kamrud; V McNeil Coffield; Gary Owens; Christin Goodman; Kim Alterson; Max Custer; Michael A Murphy; Whitney Lewis; Sarah Timberlake; Elizabeth K Wansley; Peter Berglund; Jonathan Smith
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 2.  The role of RNAi and microRNAs in animal virus replication and antiviral immunity.

Authors:  Jennifer L Umbach; Bryan R Cullen
Journal:  Genes Dev       Date:  2009-05-15       Impact factor: 11.361

Review 3.  Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications.

Authors:  Brian D Brown; Luigi Naldini
Journal:  Nat Rev Genet       Date:  2009-08       Impact factor: 53.242

Review 4.  Current issues and future directions of oncolytic adenoviruses.

Authors:  Masato Yamamoto; David T Curiel
Journal:  Mol Ther       Date:  2009-11-24       Impact factor: 11.454

5.  miRNA-mediated silencing in hepatocytes can increase adaptive immune responses to adenovirus vector-delivered transgenic antigens.

Authors:  Matthias W Kron; Sigrid Espenlaub; Tatjana Engler; Reinhold Schirmbeck; Stefan Kochanek; Florian Kreppel
Journal:  Mol Ther       Date:  2011-05-10       Impact factor: 11.454

6.  Application of mutated miR-206 target sites enables skeletal muscle-specific silencing of transgene expression of cardiotropic AAV9 vectors.

Authors:  Anja Geisler; Christian Schön; Tobias Größl; Sandra Pinkert; Elisabeth A Stein; Jens Kurreck; Roland Vetter; Henry Fechner
Journal:  Mol Ther       Date:  2013-02-26       Impact factor: 11.454

7.  Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting.

Authors:  Elizabeth J Kelly; Rebecca Nace; Glen N Barber; Stephen J Russell
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

8.  Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs.

Authors:  Hal P Bogerd; Rebecca L Skalsky; Edward M Kennedy; Yuki Furuse; Adam W Whisnant; Omar Flores; Kimberly L W Schultz; Nicole Putnam; Nicholas J Barrows; Barbara Sherry; Frank Scholle; Mariano A Garcia-Blanco; Diane E Griffin; Bryan R Cullen
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

9.  Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells.

Authors:  Ryan Cawood; Hannah H Chen; Fionnadh Carroll; Miriam Bazan-Peregrino; Nico van Rooijen; Leonard W Seymour
Journal:  PLoS Pathog       Date:  2009-05-22       Impact factor: 6.823

10.  p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication.

Authors:  Engin Gürlevik; Norman Woller; Peter Schache; Nisar P Malek; Thomas C Wirth; Lars Zender; Michael P Manns; Stefan Kubicka; Florian Kühnel
Journal:  Nucleic Acids Res       Date:  2009-05-14       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.